Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

Cecilia A. Peabody; M. Dhyanne Warner; Edith Markoff; Andrew R. Hoffman; Darrell M. Wilson; John G. Csernansky

doi:10.1016/0165-1781(90)90043-5

Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

Cecilia A. Peabody^*, M. Dhyanne Warner, Edith Markoff, Andrew R. Hoffman, Darrell M. Wilson, John G. Csernansky

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Growth hormone releasing hormone, a 44-amino acid peptide (GHRH-44), was administered (1 mug/kg i.v.) to 6 normal controls, 10 schizophrenic subjects, and 7 depressed subjects. A significantly lower growth hormone (GH) response was found in the schizophrenic and depressed groups. Two molecular forms of GH, 22K GH and 20K GH, were also measured but did not further differentiate the three groups of subjects.

Original language	English (US)
Pages (from-to)	269-276
Number of pages	8
Journal	Psychiatry Research
Volume	33
Issue number	3
DOIs	https://doi.org/10.1016/0165-1781(90)90043-5
State	Published - Sep 1990

Keywords

Growth hormone releasing hormone, growth hormone, depression, schizophrenia

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/0165-1781(90)90043-5

Cite this

@article{1b36f3b1c12649699a4918dbbb3765ea,

title = "Growth hormone response to growth hormone releasing hormone in depression and schizophrenia",

abstract = "Growth hormone releasing hormone, a 44-amino acid peptide (GHRH-44), was administered (1 mug/kg i.v.) to 6 normal controls, 10 schizophrenic subjects, and 7 depressed subjects. A significantly lower growth hormone (GH) response was found in the schizophrenic and depressed groups. Two molecular forms of GH, 22K GH and 20K GH, were also measured but did not further differentiate the three groups of subjects.",

keywords = "Growth hormone releasing hormone, growth hormone, depression, schizophrenia",

author = "Peabody, {Cecilia A.} and Warner, {M. Dhyanne} and Edith Markoff and Hoffman, {Andrew R.} and Wilson, {Darrell M.} and Csernansky, {John G.}",

note = "Funding Information: Acknowledgments. The research reported was supported in part by NIMH grant 30854,N IH grant AG01312, and a special grant of the Medical Research Service of the Veterans Administration (now Department of Veteran Affairs) to the Schizophrenia Biological Research Center at the Palo Alto VA Medical Center.",

year = "1990",

month = sep,

doi = "10.1016/0165-1781(90)90043-5",

language = "English (US)",

volume = "33",

pages = "269--276",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

AU - Peabody, Cecilia A.

AU - Warner, M. Dhyanne

AU - Markoff, Edith

AU - Hoffman, Andrew R.

AU - Wilson, Darrell M.

AU - Csernansky, John G.

N1 - Funding Information: Acknowledgments. The research reported was supported in part by NIMH grant 30854,N IH grant AG01312, and a special grant of the Medical Research Service of the Veterans Administration (now Department of Veteran Affairs) to the Schizophrenia Biological Research Center at the Palo Alto VA Medical Center.

PY - 1990/9

Y1 - 1990/9

N2 - Growth hormone releasing hormone, a 44-amino acid peptide (GHRH-44), was administered (1 mug/kg i.v.) to 6 normal controls, 10 schizophrenic subjects, and 7 depressed subjects. A significantly lower growth hormone (GH) response was found in the schizophrenic and depressed groups. Two molecular forms of GH, 22K GH and 20K GH, were also measured but did not further differentiate the three groups of subjects.

AB - Growth hormone releasing hormone, a 44-amino acid peptide (GHRH-44), was administered (1 mug/kg i.v.) to 6 normal controls, 10 schizophrenic subjects, and 7 depressed subjects. A significantly lower growth hormone (GH) response was found in the schizophrenic and depressed groups. Two molecular forms of GH, 22K GH and 20K GH, were also measured but did not further differentiate the three groups of subjects.

KW - Growth hormone releasing hormone, growth hormone, depression, schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0025127499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025127499&partnerID=8YFLogxK

U2 - 10.1016/0165-1781(90)90043-5

DO - 10.1016/0165-1781(90)90043-5

M3 - Article

C2 - 2243902

AN - SCOPUS:0025127499

SN - 0165-1781

VL - 33

SP - 269

EP - 276

JO - Psychiatry Research

JF - Psychiatry Research

IS - 3

ER -

Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this